4-nitrobenzyl bromide

We are 4-nitrobenzyl bromide CAS:100-11-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-nitrobenzyl bromide
CAS.NO:100-11-8
Synonyms:4-nitrobenzyl bromide
1-(Bromomethyl)-4-nitrobenzene
4-Nitrobenzyl bromide
α-Bromo-4-nitrotoluene
 
Physical and Chemical Properties:
Density 1.7±0.1 g/cm3
Boiling Point 304.2±17.0 °C at 760 mmHg
Melting Point 98 °C
Molecular Formula C7H6BrNO2
Molecular Weight 216.032
Flash Point 137.8±20.9 °C
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.612
 
Specification:
Appearance:White to light yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Flucycloxuron(CAS:113036-88-7/94050-52-9).

4-nitrobenzyl bromide


Related News: Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.3862-73-5 Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.5-Chloro-2-methoxyphenylboronic acid At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.3,4-Difluoronitrobenzene At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.Targets within the tumor microenvironment may include both plasma membrane proteins as well as proteins typically secreted into the extracellular space.

Related Products
Product Name
4-[(2-Aminoethyl)(5-chloro-2-benzoxazolyl)amino]-2-butanone methanesulfonate View Details
Tetrachloropropene View Details
Methyl 2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-4-fluorobenzoate View Details
(7-Azabenzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate manufacturer 4-Bromo-3-fluorobenzotrifluoride manufacturer 2,4,6-TRICHLOROPHENYL ISOTHIOCYANATE manufacturer 1,7-DIIODOHEPTANE manufacturer (3aS,6aR)-4-methoxy-3a,4,6,6a-tetrahydro-3H-furo[2,3-c]furan-2-one manufacturer